Journal article
Endothelium-specific gene and stem cell-based therapy for erectile dysfunction
Asian journal of andrology, Vol.10(1), pp.14-22
01/2008
DOI: 10.1111/j.1745-7262.2008.00362.x
PMID: 18087639
Abstract
Erectile dysfunction (ED) commonly results from endothelial dysfunction of the systemic vasculature. Although phosphodiesterase type 5 (PDE-5) inhibitors are effective at treating most cases of ED, they must be taken routinely and are ineffectual for a meaningful number of men. In recent years gene and stem cell-based therapies targeted at the penile endothelium have been gaining momentum in preclinical studies. These early studies reveal that gene and stem cell-based therapies may be both enduring and efficacious, and may eventually lead to a cure for ED. The following review will highlight our current understanding of endothelial-specific gene and stem cell-based therapies performed to date in a number of experimental animal models.
Details
- Title: Subtitle
- Endothelium-specific gene and stem cell-based therapy for erectile dysfunction
- Creators
- Travis D Strong - Department of Urology, Johns Hopkins Hospital, Baltimore, MD 21287, USAMilena A GebskaArthur L BurnettHunter C ChampionTrinity J Bivalacqua
- Resource Type
- Journal article
- Publication Details
- Asian journal of andrology, Vol.10(1), pp.14-22
- DOI
- 10.1111/j.1745-7262.2008.00362.x
- PMID
- 18087639
- NLM abbreviation
- Asian J Androl
- ISSN
- 1008-682X
- eISSN
- 1745-7262
- Language
- English
- Date published
- 01/2008
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984094315602771
Metrics
25 Record Views